Why vaccines are not able to eliminate Covid-19: QuickTake

Hungary's Coronavirus Vaccination Program Underway

Photographer: Akos Stiller / Bloomberg

The road to eliminating Covid-19 is paved long and with uncertainty. Many countries count on vaccines to build up sufficient immunity in their population so that SARS-CoV-2 cannot find susceptible people to infect, causing the transmission of the coronavirus to slow down and eventually stop. But even with the introduction of very effective vaccines, the coverage of the vaccine may not reach the level – the so-called pillow immunity threshold – soon. For one thing it is not known what level of immunity is required and whether vaccines will be strong enough to achieve it. There is also the threat of emerging coronavirus variants that may impair the effectiveness of vaccinations.

1. Can Covid-19 be eradicated?

No. Till now only one human disease – smallpox – is official eradicated; that is, reduced to zero cases and held there long-term without continuous intervention measures. Smallpox has been eliminated thanks to an extremely effective vaccine and the fact that humans are the only mammals naturally susceptible to infection with the variola virus that causes the debilitating, sometimes fatal disease. Humans are the only known reservoir of poliovirus, but it still spreads in some countries, which cause crippling diseases, despite the widespread use of effective vaccinations and a 32-year-old global eradication effort. It is suspected that SARS-CoV-2 persists in nature in horseshoe iron bats, and it is known to infect minks, cats, gorillas and other animals. To eradicate the virus, it must be banned from every susceptible species, which is not feasible. In countries that have successfully suppressed Covid-19 cases, disease elimination has been suggested rather.

2. What is elimination?

It was then that attempts to suppress an outbreak led to zero new cases of a disease or infection in a particular area over a long period of time. There is no official definition of how long it should be. One suggestion is to make it 28 days, corresponding to twice as long as the outer series of SARS-CoV-2 incubation period – the time between infection and the onset of symptoms. Some countries, such as New Zealand, have achieved zero new business over long periods of time by bringing about border closures, closures and diligent detection and isolation of businesses. While a pandemic, which is an outbreak of a new infection across the continents, sustaining the eradication of any contagious disease nationwide challenging, if not impossible, due to the threat of the virus re-entering the country by infected international travelers.

Will vaccines eliminate Covid-19?

That’s hard to say. It is not known what a portion of the population must have immunity to prevent the coronavirus from circulating, or that even the most potent vaccines can spread. One study estimated that in order to stop the transmission, 55% to 82% of the population must have immunity, which can be achieved by repairing an infection or by vaccination. Herd immunity was not achieved in Manaus, the capital of the Amazon state in Brazil, even after about 76% of the population was infected. Nevertheless, there is reason to believe that mass vaccinations will have a stronger effect because the vaccines appear to be stronger and more durable than a previous infection.

4. How effective will vaccines be?

There is good evidence that the shots made by Pfizer Inc.-BioNTech SE en Moderna Inc. is very effective – up to 95% – in preventing recipients from developing Covid-19 themselves. However, no data have been released on their ability to prevent humans from developing asymptomatic infections or transmitting the virus to others. The gold standard in vaccination is to stop infection as well as diseases, by the so-called sterilization of immunity. But this is not always achieved. For example, the measles vaccine prevents infection so that vaccinated people do not spread the virus, while the vaccine for whooping cough is good for protecting against serious diseases but is less effective at stopping infection. Encouraging, a a study of Moderna’s Covid vaccine in monkeys has suggested that it reduces the transmission of the virus, if it does not occur completely. Clinical trials using The AstraZeneca Plc vaccine suggests that it can be less than 60% effective in stopping infections, making it unlikely that herd immunity will be acquired, even if everyone in a population receives two doses.

5. How can variants of the virus be activated?

Researchers have studied the ability of antibodies in the blood of recovered Covid-19 patients to study the new, rapidly spreading B.1.1.7, 501Y.V2 and P.1 variants first found in the UK, South Africa and Brazil reported, to block. Some research has indicated that these strains can escape the immune protection of natural infections. The scientists warned that laboratory studies are only an indication and that there is no evidence that they occur in the community, or that antibodies generated by vaccine will be less effective against the new strain.

6. Should Covid-19 vaccines prevent infection to limit cases?

.Source